Immunogenicity, reactogenicity and safety of the 10-valent pneumococcal nontypeableHaemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) in Mexican infants

Safety and immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Chilean children

(2011) Rosanna Lagos et al.   Human vaccines & immunotherapeutics

Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?

(2010) William P Hausdorff et al.   BMC Pediatrics

Impact of the Conjugation Method on the Immunogenicity ofStreptococcus pneumoniaeSerotype 19F Polysaccharide in Conjugate Vaccines

(2010) Jan Poolman et al.   Clinical and Vaccine Immunology

Serotype-Specific Hyporesponsiveness to Pneumococcal Conjugate Vaccine in Infants Carrying Pneumococcus at the Time of Vaccination

(2010) Merja Väkeväinen et al.   JOURNAL OF PEDIATRICS

Safety and Immunogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine Coadministered With Measles-Mumps-Rubella-Varicella Vaccine in Children Aged 12 to 16 Months

(2010) Timo Vesikari et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

SAFETY AND IMMUNOGENICITY OF A BOOSTER DOSE OF THE 10-VALENT PNEUMOCOCCAL NONTYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN D CONJUGATE VACCINE COADMINISTERED WITH DTPW-HBV/HIB AND POLIOVIRUS VACCINES

(2010) Nancy Bermal et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Chinchilla as a robust, reproducible and polymicrobial model of otitis media and its prevention

(2009) Lauren O Bakaletz   Expert Review of Vaccines

Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials

(2009) Roman Prymula et al.   LANCET

Laboratory-Based Surveillance of Streptococcus pneumoniae Invasive Disease in Children in 10 Latin American Countries

(2009) Elizabeth Castañeda et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity of a 2-Dose Priming and Booster Vaccination With the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine

(2009) Sven Arne Silfverdal et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Safety and Reactogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Routine Childhood Vaccines

(2009) Bertrand Chevallier et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Different Neisseria meningitidis Serogroup C Conjugate Vaccines

(2009) Jacek Wysocki et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Coadministered With DTPw-HBV/Hib and Poliovirus Vaccines: Assessment of Immunogenicity

(2009) Nancy Bermal et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity of Routinely Used Childhood Vaccines When Coadministered With the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV)

(2009) Markus Knuf et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Efficacy of an 11-Valent Pneumococcal Conjugate Vaccine Against Radiologically Confirmed Pneumonia Among Children Less Than 2 Years of Age in the Philippines

(2009) Marilla G. Lucero et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM Vaccine

(2009) Timo Vesikari et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Estimating the direct impact of new conjugate vaccines against invasive pneumococcal disease

(2009) W.P. Hausdorff et al.   VACCINE

Protein D of Haemophilus influenzae: A Protective Nontypeable H. influenzae Antigen and a Carrier for Pneumococcal Conjugate Vaccines

(2008) A. Forsgren et al.   CLINICAL INFECTIOUS DISEASES

Combination vaccines containing DTPa–Hib: impact of IPV and coadministration of CRM197 conjugates

(2008) Ron Dagan et al.   Expert Review of Vaccines

Safety and immunogenicity of CRM197-conjugated pneumococcal–meningococcal C combination vaccine (9vPnC–MnCC) whether given in two or three primary doses

(2008) Sigurveig Th. Sigurdardottir et al.   VACCINE